HT
CERE

Headlands Technologies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Headlands Technologies’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,630
Closed -$516K – 1623
2024
Q2 		$516K Buy
12,630
+12,019
+1,967% +$501K 0.05% 272
2024
Q1 		$25.8K Buy
+611
New +$25.7K 0.01% 863

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Headlands Technologies's CERE Position: Q3 2024 in Review

Headlands Technologies sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 12,630 shares — an estimated $516K sold.

Headlands Technologies first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $516K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Headlands Technologies reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Headlands Technologies sold 12,630 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $516K.
  • Headlands Technologies first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Headlands Technologies's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $516K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Headlands Technologies's 13F filing for Q3 2024, filed 12 Nov 2024.